200 related articles for article (PubMed ID: 31534203)
1. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
[TBL] [Abstract][Full Text] [Related]
2. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
[TBL] [Abstract][Full Text] [Related]
3. Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast.
Stanciu-Pop C; Nollevaux MC; Berlière M; Duhoux FP; Fellah L; Galant C; Van Bockstal MR
Virchows Arch; 2021 Jul; 479(1):33-43. PubMed ID: 33502600
[TBL] [Abstract][Full Text] [Related]
4. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR; François A; Altinay S; Arnould L; Balkenhol M; Broeckx G; Burguès O; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Hastir D; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchiò C; Martin Martinez MD; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban A; Sinke R; Stanciu-Pop CM; van Deurzen CHM; Van de Vijver KK; Van Rompuy AS; Vincent-Salomon A; Wen HY; Wong S; Bouzin C; Galant C
Mod Pathol; 2021 Dec; 34(12):2130-2140. PubMed ID: 34218258
[TBL] [Abstract][Full Text] [Related]
6. Variability in grading of ductal carcinoma in situ among an international group of pathologists.
van Seijen M; Jóźwiak K; Pinder SE; Hall A; Krishnamurthy S; Thomas JS; Collins LC; Bijron J; Bart J; Cohen D; Ng W; Bouybayoune I; Stobart H; Hudecek J; Schaapveld M; Thompson A; Lips EH; Wesseling J;
J Pathol Clin Res; 2021 May; 7(3):233-242. PubMed ID: 33620141
[TBL] [Abstract][Full Text] [Related]
7. Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Van Bockstal M; Lambein K; Smeets A; Slembrouck L; Neven P; Nevelsteen I; Weltens C; Van Limbergen E; Christiaens MR; Van Ongeval C; Wildiers H; Libbrecht L; Floris G
Eur J Surg Oncol; 2019 Apr; 45(4):550-559. PubMed ID: 30454971
[TBL] [Abstract][Full Text] [Related]
8. Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
Van Bockstal MR; Berlière M; Duhoux FP; Galant C
Am J Clin Pathol; 2020 Oct; 154(5):596-609. PubMed ID: 32566938
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability.
Qiu L; Mais DD; Nicolas M; Nanyes J; Kist K; Nazarullah A
Int J Surg Pathol; 2019 Oct; 27(7):736-743. PubMed ID: 31187678
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
Jackson SL; Frederick PD; Pepe MS; Nelson HD; Weaver DL; Allison KH; Carney PA; Geller BM; Tosteson AN; Onega T; Elmore JG
Ann Surg Oncol; 2017 May; 24(5):1234-1241. PubMed ID: 27913946
[TBL] [Abstract][Full Text] [Related]
11. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Gomes DS; Porto SS; Balabram D; Gobbi H
Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
[TBL] [Abstract][Full Text] [Related]
12. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
Choi YJ; Pinto MM; Hao L; Riba AK
Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
Pruneri G; Lazzeroni M; Bagnardi V; Tiburzio GB; Rotmensz N; DeCensi A; Guerrieri-Gonzaga A; Vingiani A; Curigliano G; Zurrida S; Bassi F; Salgado R; Van den Eynden G; Loi S; Denkert C; Bonanni B; Viale G
Ann Oncol; 2017 Feb; 28(2):321-328. PubMed ID: 28426105
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Groen EJ; Hudecek J; Mulder L; van Seijen M; Almekinders MM; Alexov S; Kovács A; Ryska A; Varga Z; Andreu Navarro FJ; Bianchi S; Vreuls W; Balslev E; Boot MV; Kulka J; Chmielik E; Barbé E; de Rooij MJ; Vos W; Farkas A; Leeuwis-Fedorovich NE; Regitnig P; Westenend PJ; Kooreman LFS; Quinn C; Floris G; Cserni G; van Diest PJ; Lips EH; Schaapveld M; Wesseling J;
Breast Cancer Res Treat; 2020 Oct; 183(3):759-770. PubMed ID: 32734520
[TBL] [Abstract][Full Text] [Related]
15. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
16. Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
Swisher SK; Wu Y; Castaneda CA; Lyons GR; Yang F; Tapia C; Wang X; Casavilca SA; Bassett R; Castillo M; Sahin A; Mittendorf EA
Ann Surg Oncol; 2016 Jul; 23(7):2242-8. PubMed ID: 26965699
[TBL] [Abstract][Full Text] [Related]
17. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
Sneige N; Lagios MD; Schwarting R; Colburn W; Atkinson E; Weber D; Sahin A; Kemp B; Hoque A; Risin S; Sabichi A; Boone C; Dhingra K; Kelloff G; Lippman S
Hum Pathol; 1999 Mar; 30(3):257-62. PubMed ID: 10088542
[TBL] [Abstract][Full Text] [Related]
18. Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.
Komforti M; Badve SS; Harmon B; Lo Y; Fineberg S
Histopathology; 2020 Nov; 77(5):749-759. PubMed ID: 32557780
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
[TBL] [Abstract][Full Text] [Related]
20. Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.
Tramm T; Di Caterino T; Jylling AB; Lelkaitis G; Lænkholm AV; Ragó P; Tabor TP; Talman MM; Vouza E;
Acta Oncol; 2018 Jan; 57(1):90-94. PubMed ID: 29168428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
